叹气对急性低氧性呼吸衰竭患者死亡率影响的异质性:PROTECTION研究启示
PROTECTION多中心临床试验的预设亚组分析,纳入接受压力支持通气(PSV)的急性低氧性呼吸衰竭(AHRF)患者,随机分为叹气组与无叹气组。对基线叹气试验无反应者,叹气组28天死亡率17% vs 无叹气组36%(log-rank p=0.031);低PEEP(≤8 cmH2O)患者中,叹气组13% vs 无叹气组31%(log-rank p=0.021)。高PEEP(>8 cmH2O)患者及叹气试验有反应者中,叹气与死亡率无差异。7天时叹气组潮气量、呼吸频率和通气比值下降,通气比值与死亡率及成功拔管相关。
要点
- 对基线叹气试验无反应的AHRF患者,PSV联合叹气较无叹气降低28天死亡率(17% vs 36%,log-rank p=0.031)。
- 低PEEP(原文界值:≤8 cmH2O组,具体界值表述见原文)患者中,叹气组28天死亡率低于无叹气组(13% vs 31%,log-rank p=0.021)。
- PEEP>8 cmH2O患者中,叹气与无叹气28天死亡率无差异。
- 叹气试验有反应者中,叹气与28天死亡率无差异。
- 7天时叹气组潮气量、呼吸频率和通气比值较无叹气组下降,通气比值与无反应者和低PEEP患者的死亡率及成功拔管相关。
适用人群与场景
- 纳入PROTECTION多中心临床试验的急性低氧性呼吸衰竭(AHRF)接受辅助机械通气(PSV)的患者。
- 按对基线叹气试验的氧合反应分为有反应者和无反应者;按设置的PEEP水平分为高PEEP和低PEEP组。
诊断标准与关键阈值
- PEEP分组:高PEEP(>8 cmH2O)与低PEEP(原文低PEEP组界值未明确,仅表述为Low-PEEP)。
处置流程与药物剂量
- PSV联合叹气(Sigh组)与PSV无叹气(No Sigh组)比较;叹气具体参数(频率、压力、容量)原文未给出。
研究设计与关键结果
- 研究类型:PROTECTION多中心临床试验的预设亚组分析;样本量:总样本量原文未报告,无反应者中56例随机至叹气组(55%),低PEEP组中54例随机至叹气组(48%)。
- 无反应者:叹气组28天死亡率17% vs 无叹气组36%,log-rank p=0.031;有反应者中叹气与死亡率无差异。
- 高PEEP(>8 cmH2O)患者中叹气与无叹气死亡率无差异;低PEEP组中叹气组28天死亡率13% vs 无叹气组31%,log-rank p=0.021。
- 上述结果经多变量调整后仍稳健。
- 7天时叹气组潮气量、呼吸频率和通气比值较无叹气组下降;通气比值与无反应者和低PEEP患者的死亡率及成功拔管相关。
证据类型、等级与局限
- 证据类型:多中心随机对照试验(PROTECTION)的预设亚组分析;证据等级原文未给出。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在PSV基础上加用叹气可能降低对叹气无反应且暴露于低PEEP的AHRF患者的死亡率;无反应者的结果出乎预期。
- 作者认为,低PEEP组的结果可能提示所用PEEP不足,或低PEEP可与叹气联合使用。
- 作者认为,叹气可能通过减少生理死腔和通气强度及/或优化通气/血流匹配来降低死亡率。
指南或共识出处
- PROTECTION多中心临床试验(ClinicalTrials.gov标识符:NCT03201263)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Sigh breaths may impact outcomes in acute hypoxemic respiratory failure (AHRF) during assisted mechanical ventilation. We investigated whether sigh breaths may impact mortality in predefined subgroups of patients enrolled in the PROTECTION multicenter clinical trial according to: 1.the physiological response in oxygenation to Sigh (responders versus non-responders) and 2.the set levels of positive end-expiratory pressure (PEEP) (High vs. Low-PEEP). If mortality differed between Sigh and No Sigh, we explored physiological daily differences at 7-days.
RESULTS: Patients were randomized to pressure support ventilation (PSV) with Sigh (Sigh group) versus PSV with no sigh (No Sigh group). (1) Sighs were not associated with differences in 28-day mortality in responders to baseline sigh-test. Contrarily-in non-responders-56 patients were randomized to Sigh (55%) and 28-day mortality was lower with sighs (17%vs.36%, log-rank p = 0.031). (2) In patients with PEEP > 8cmH2O no difference in mortality was observed with sighs. With Low-PEEP, 54 patients were randomized to Sigh (48%). Mortality at 28-day was reduced in patients randomised to sighs (13%vs.31%, log-rank p = 0.021). These findings were robust to multivariable adjustments. Tidal volume, respiratory rate and ventilatory ratio decreased with Sigh as compared with No Sigh at 7-days. Ventilatory ratio was associated with mortality and successful extubation in both non-responders and Low-PEEP.
CONCLUSIONS: Addition of Sigh to PSV could reduce mortality in AHRF non-responder to Sigh and exposed to Low-PEEP. Results in non-responders were not expected. Findings in the low PEEP group may indicate that insufficient PEEP was used or that Low PEEP may be used with Sigh. Sigh may reduce mortality by decreasing physiologic dead space and ventilation intensity and/or optimizing ventilation/perfusion mismatch.
CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov; Identifier: NCT03201263.
参考来源
- Rezoagli E, Fornari C, Fumagalli R, et al. Heterogeneous impact of Sighs on mortality in patients with acute hypoxemic respiratory failure: insights from the PROTECTION study. Ann Intensive Care. 2024. PMID: 39368033. doi:10.1186/s13613-024-01385-0
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。